上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1138Please respect copyright.PENANAFfyRCj1rC5
1138Please respect copyright.PENANA9gdsDE32K8
上集:https://www.penana.com/article/4711251138Please respect copyright.PENANAuMklL7y781
1138Please respect copyright.PENANARw9cVN4SbG
1138Please respect copyright.PENANAHdCbJKQPgc
1138Please respect copyright.PENANAPc74DLmUkv
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1138Please respect copyright.PENANA8C2o3oKk9R
1138Please respect copyright.PENANAm7oAmflVw7
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1138Please respect copyright.PENANAweFASSiqPK
1138Please respect copyright.PENANArZZLiwoXL3
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1138Please respect copyright.PENANAGmTQmGSRe4
1138Please respect copyright.PENANAxEY5kNp9UY
1138Please respect copyright.PENANAzbhUeo7xQN
1138Please respect copyright.PENANAZPPtj5INla
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1138Please respect copyright.PENANAEN8OlgM1oe
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1138Please respect copyright.PENANA0nItmPjSlo
1138Please respect copyright.PENANAK6JQdo3QPX
忘記甚麼是Neoantigen的話,可重溫上一集。1138Please respect copyright.PENANA4VfCUWu8ox
1138Please respect copyright.PENANA3AGw9ER0xH
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1138Please respect copyright.PENANA7QVSOGo5Dr
1138Please respect copyright.PENANA3k6Zb6RtVk
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1138Please respect copyright.PENANA55GPs6TXeM
1138Please respect copyright.PENANAgdYDbJY4e5
1138Please respect copyright.PENANAWcZyuoPpOw
1138Please respect copyright.PENANAx2W7KpRzrG
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1138Please respect copyright.PENANAZTqnyvdfxi
1138Please respect copyright.PENANAKwZbLM6gWF
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1138Please respect copyright.PENANA3WGqQTZSJh
1138Please respect copyright.PENANAPxsK1LQYMV
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1138Please respect copyright.PENANAdfhpEJo4Nq
1138Please respect copyright.PENANA0soSntOYKP
1138Please respect copyright.PENANAlAOEvHdIpj
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1138Please respect copyright.PENANA8jCI8IlY2C
1138Please respect copyright.PENANA3RsPiTt2DN
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1138Please respect copyright.PENANAl7Xb8ovOAg
1138Please respect copyright.PENANAPdSlzGzu48
1138Please respect copyright.PENANAhbYmBY0C8y
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1138Please respect copyright.PENANAuMga5ngrBS
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1138Please respect copyright.PENANA1Aey0j4Acm
1138Please respect copyright.PENANASuTqx3Ex0i
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1138Please respect copyright.PENANA8c2HhiUAOF
1138Please respect copyright.PENANA1DdEK0CRFM
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1138Please respect copyright.PENANAWcGT3GrjBE
1138Please respect copyright.PENANA7zNUh5M4H0
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1138Please respect copyright.PENANATLVaEKPBbm
1138Please respect copyright.PENANAwloiS6pYTc
1138Please respect copyright.PENANANj4JgOogxD
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1138Please respect copyright.PENANAJ3p9RjArG0
1138Please respect copyright.PENANAdzPdELmPe5
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1138Please respect copyright.PENANA2ssm31Sx5I
1138Please respect copyright.PENANAFrUo6sZKWv
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1138Please respect copyright.PENANAL314inDR45
1138Please respect copyright.PENANAdbvL6JLbo4
Link:1138Please respect copyright.PENANAoOzlB16OPz
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1138Please respect copyright.PENANA4FAtASohcx
1138Please respect copyright.PENANATcGGVzjY7o
1138Please respect copyright.PENANAo4BoCYP1PD
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1138Please respect copyright.PENANArSb4hI7bWD